F2 GC, LLC

Track record of F2 GC, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of F2 GC, LLC

Co-insiders of F2 GC, LLC

• AHMED NADIMCullinan Therapeutics, Inc.
• Allen Andrew RCullinan Therapeutics, Inc.
• Baeuerle PatrickCullinan Therapeutics, Inc.
• BIOTECHNOLOGY VALUE FUND II LPCullinan Therapeutics, Inc.
• BIOTECHNOLOGY VALUE FUND L PCullinan Therapeutics, Inc.
• Biotechnology Value Trading Fund OS LPCullinan Therapeutics, Inc.
• BVF GP HOLDINGS LLCCullinan Therapeutics, Inc.
• BVF I GP LLCCullinan Therapeutics, Inc.
• BVF II GP LLCCullinan Therapeutics, Inc.
• BVF INC/ILCullinan Therapeutics, Inc.
• BVF PARTNERS L P/ILCullinan Therapeutics, Inc.
• BVF Partners OS Ltd.Cullinan Therapeutics, Inc.
• Doyle MittieCullinan Therapeutics, Inc.
• Ebeling ThomasCullinan Therapeutics, Inc.
• F2 Bioscience I 2017 LtdCullinan Therapeutics, Inc.
• F2 Bio TD, LLCCullinan Therapeutics, Inc.
• F2 MC, LLCCullinan Therapeutics, Inc.
• F2 MG LtdCullinan Therapeutics, Inc.
• F2 - TPO Investments LLCCullinan Therapeutics, Inc.
• F2 Vision SCSCullinan Therapeutics, Inc.
• Fenton Mary KayCullinan Therapeutics, Inc.
• GADICKE ANSBERTCullinan Therapeutics, Inc.
• Globeways Holdings LtdCullinan Therapeutics, Inc.
• Hughes OwenCullinan Therapeutics, Inc.
• Jones Jeffrey AlanCullinan Therapeutics, Inc.
• Jovan-Embiricos MoranaCullinan Therapeutics, Inc.
• Keane Raymond TCullinan Therapeutics, Inc.
• LAMPERT MARK NCullinan Therapeutics, Inc.
• Lynx1 Capital Management LPCullinan Therapeutics, Inc.
• Martin Anne-MarieCullinan Therapeutics, Inc.
• Meek David D.Cullinan Therapeutics, Inc.
• Michaelson JenniferCullinan Therapeutics, Inc.
• MPM Oncology Impact Management GP LLCCullinan Therapeutics, Inc.
• MPM Oncology Impact Management LPCullinan Therapeutics, Inc.
• Nguyen NateCullinan Therapeutics, Inc.
• Nichols WestonCullinan Therapeutics, Inc.
• Oncology Impact Fund (Cayman) Management L.P.Cullinan Therapeutics, Inc.
• Rosenberg AnthonyCullinan Therapeutics, Inc.
• Ryan David P.Cullinan Therapeutics, Inc.
• Savill CorrineCullinan Therapeutics, Inc.
• SUMER JACQUELYN LCullinan Therapeutics, Inc.
• Thistle MaryCullinan Therapeutics, Inc.
• Trigilio JeffreyCullinan Therapeutics, Inc.
• UBS Oncology Impact Fund L.P.Cullinan Therapeutics, Inc.
• Webster Stephen WCullinan Therapeutics, Inc.
• Wigginton Jon MarcCullinan Therapeutics, Inc.
• Zawel LeighCullinan Therapeutics, Inc.